Almost three years on from the first New Zealand coronavirus cases and across the country there is a subset of patients that sustain an acute SARS CoV-2 infection (1). They develop a wide range of persistent symptoms that do not resolve over many months. This condition has been labelled Long COVID or Post-acute Sequelae of COVID-19 (PASC) (1).
Long COVID has been estimated to affect 30% to 45% of populations around the world (2, 3). Due to the majority of the NZ population contracting the virus later than the rest of the world the percentage of the population affected by Long COVID is still emerging.